BMC Genomics

official impact factor 4.21

Open Access Highly Access Research article

cGMP-independent nitric oxide signaling and regulation of the cell cycle

Xiaolin Cui1, Jianhua Zhang1, Penglin Ma1,4, Daniela E Myers1, Ilana G Goldberg1, Kelly J Sittler1, Jennifer J Barb2, Peter J Munson2, Ana P Cintron1, J Philip McCoy3, Shuibang Wang1 and Robert L Danner1*

Author Affiliations

1 Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA

2 Mathematical and Statistical Computing Laboratory, Division of Computational Bioscience, Center for Information Technology, National Institutes of Health, Bethesda, Maryland, USA

3 Flow Cytometry Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA

4 Intensive Care Unit of the Military 309th Hospital, Haidian District of Beijing, People's Republic of China

For all author emails, please log on.

BMC Genomics 2005, 6:151 doi:10.1186/1471-2164-6-151

Published: 3 November 2005

Abstract

Background

Regulatory functions of nitric oxide (NO) that bypass the second messenger cGMP are incompletely understood. Here, cGMP-independent effects of NOon gene expression were globally examined in U937 cells, a human monoblastoid line that constitutively lacks soluble guanylate cyclase. Differentiated U937 cells (>80% in G0/G1) were exposed to S-nitrosoglutathione, a NOdonor, or glutathione alone (control) for 6 h without or with dibutyryl-cAMP (Bt2cAMP), and then harvested to extract total RNA for microarray analysis. Bt2cAMP was used to block signaling attributable to NO-induced decreases in cAMP.

Results

NOregulated 110 transcripts that annotated disproportionately to the cell cycle and cell proliferation (47/110, 43%) and more frequently than expected contained AU-rich, post-transcriptional regulatory elements (ARE). Bt2cAMP regulated 106 genes; cell cycle gene enrichment did not reach significance. Like NO, Bt2cAMP was associated with ARE-containing transcripts. A comparison of NOand Bt2cAMP effects showed that NOregulation of cell cycle genes was independent of its ability to interfere with cAMP signaling. Cell cycle genes induced by NOannotated to G1/S (7/8) and included E2F1 and p21/Waf1/Cip1; 6 of these 7 were E2F target genes involved in G1/S transition. Repressed genes were G2/M associated (24/27); 8 of 27 were known targets of p21. E2F1 mRNA and protein were increased by NO, as was E2F1 binding to E2F promoter elements. NOactivated p38 MAPK, stabilizing p21 mRNA (an ARE-containing transcript) and increasing p21 protein; this increased protein binding to CDE/CHR promoter sites of p21 target genes, repressing key G2/M phase genes, and increasing the proportion of cells in G2/M.

Conclusion

NOcoordinates a highly integrated program of cell cycle arrest that regulates a large number of genes, but does not require signaling through cGMP. In humans, antiproliferative effects of NOmay rely substantially on cGMP-independent mechanisms. Stress kinase signaling and alterations in mRNA stability appear to be major pathways by which NOregulates the transcriptome.